常州市存仁生物工程有限公司

GSK256066

GSK256066

Description of:GSK256066
GSK256066 is an exceptionally high affinity and selective inhibitor of PDE4 that inhibits PDE4 isoforms A-D with equ...
更多>>
Cilomilast(SB-207499)

Cilomilast(SB-207499)

Description of:Cilomilast(SB-207499)
Cilomilast (SB-207499) inhibits HPDE4 and LPDE4 catalytic activity with equal potency (Ki ≈100 nM). ...
更多>>
TH-302

TH-302

Description of:TH-302
TH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug. Theoretical analysis:T...
更多>>
TAK-700 (Orteronel)

TAK-700 (Orteronel)

Description of:TAK-700 (Orteronel)
orteronel(TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prost...
更多>>
Avasimibe(CI-1011)

Avasimibe(CI-1011)

Description of:Avasimibe(CI-1011)
Avasimibe (CI-1011) is an orally bioavailable Acyl-CoA:Cholesterol O-Acyltransferase (ACAT) inhibitor. T...
更多>>
Apixaban

Apixaban

Description of:Apixaban
Apixaban is a compound being investigated as an anticoagulant. Apixaban has similar affinity for human and rabbit facto...
更多>>
Rivaroxaban(Xarelto)

Rivaroxaban(Xarelto)

Description of:Rivaroxaban(Xarelto)
Rivaroxaban significantly reduced the primary efficacy end point, as compared with placebo, with respective...
更多>>
总数: 17 页: 2 / 2 首页 ←上一页 下一页→ 末页

在线联系

点击这里给我发消息